- Fowke KR, D’Amico R, Chernoff DN, Pottage JC Jr, Benson CA, Sha BE, et al. Immunologic and virologic evaluation after influenza vaccination of HIV-1 infected patients. AIDS 1997; 11: 1013–21.
- Kramer P, McClain CJ. Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med 1981; 305: 1262–4.
- Meredith CG, Christian CD, Johnson RF, Troxell R, Davis GL, Schenker S. Effects of influenza virus vaccine on hepatic drug metabolism. Clin Pharmacol Ther 1985; 37: 396–401.
- Patriarca PA, Kendall AP, Stricof RL, Weber JA, Meissner MK, Dateno B. Influenza vaccination and warfarin or theophylline toxicity in nursing home residents. N Engl J Med 1983; 308: 1601–2.
- Hannan SE, May JJ, Pratt DS, Richtsmeier WJ, Bertino JS. The effect of whole virus influenza vaccination on theophylline pharmacokinetics. Am Rev Respir Dis 1988; 137: 903–6.
- Woolf E, Au T, Haddix H, Matuszewski B. Determination of L-73S524, a human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching. J Chromatogr A 1995; 692: 45–52.
- Hoetelmans RMW, Meenhorst PL, Mulder JW, Burger DM, Koks CHW, Beijnen JH. Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir and ritonavir. Pharm World Sci 1997; 19: 159–65.
Scandinavian Journal of Infectious Diseases
Volume 32, 2000 - Issue 4